| 产品描述: | SSAA09E3 is a SARS-CoV entry inhibitor that inhibits SARS/HIV pseudotyped virus entry with an EC50 of 9.7 μM in 293T cells and inhibits SARS-CoV infection of Vero cells with an EC50 of 0.15 μM |
| 靶点: |
SARS-CoV |
| 体外研究: |
SSAA09E3 blocks viral entry by inhibiting fusion of the viral membrane with the host cell membrane. SSAA09E3 inhibits later stages of viral entry. |
| 参考文献: |
1. Ghosh AK, et al. Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics. ChemMedChem. 2020 Jun 4;15(11):907-932.
2. Adedeji AO, et al. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J Virol. 2013 Jul;87(14):8017-28. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.055 ml |
15.275 ml |
30.55 ml |
| 5 mM |
0.611 ml |
3.055 ml |
6.11 ml |
| 10 mM |
0.306 ml |
1.528 ml |
3.055 ml |
| 50 mM |
0.061 ml |
0.306 ml |
0.611 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |